Tejnaksh Healthcare (BOM:539428) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539428 Tejnaksh Healthcare Ltd BOM:539428
65 GF Score
Price ₹13.60
GF Value ₹20.01
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Tejnaksh Healthcare Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Tejnaksh Healthcare is: High Risk: Good fundamentals, beware of shrinking business.

Tejnaksh Healthcare  (BOM:539428) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Tejnaksh Healthcare Risk Assessment Related Terms

BOM:539428 vs HCA, THC, EHC: Risk Assessment Comparison

For the Medical Care Facilities subindustry, Tejnaksh Healthcare's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tejnaksh Healthcare Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tejnaksh Healthcare's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Tejnaksh Healthcare's Risk Assessment falls into.


BOM:539428
65GF Score
Tejnaksh Healthcare Ltd BOM:539428
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?

Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued. The current stock price of ₹13.60 is trading 32% below its estimated GF Value™ of ₹20.01. GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.

Key valuation signals for BOM:539428:

  • Risk Assessment:
  • GF Value™: ₹20.01 vs. price of ₹13.60 (32% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tejnaksh Healthcare Business Description

Address Institute of Urology, Sakri Road, Dhule, MH, IND, 424 001
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
65GF Score

Get the complete analysis for BOM:539428

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.60
Price
₹20.01
GF Value